The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 08, 2021

Filed:

Aug. 08, 2018
Applicant:

Infinitus (China) Company Ltd., Guangdong, CN;

Inventors:

Fangli Ma, Guangdong, CN;

Yuanyuan Wang, Guangdong, CN;

Minghua Hu, Guangdong, CN;

Renhuai Cong, Guangdong, CN;

Lingyun Xiao, Guangdong, CN;

Chung Wah Ma, Guangdong, CN;

Assignee:
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 36/54 (2006.01); A61K 36/00 (2006.01); A61K 36/815 (2006.01); A23L 33/105 (2016.01); A23L 33/115 (2016.01); A23L 33/12 (2016.01); A23L 33/125 (2016.01); A61P 35/00 (2006.01); A61K 31/715 (2006.01); A61K 36/61 (2006.01); A61K 36/8969 (2006.01);
U.S. Cl.
CPC ...
A61K 36/815 (2013.01); A23L 33/105 (2016.08); A23L 33/115 (2016.08); A23L 33/12 (2016.08); A23L 33/125 (2016.08); A61K 31/715 (2013.01); A61K 36/54 (2013.01); A61K 36/61 (2013.01); A61K 36/8969 (2013.01); A61P 35/00 (2018.01); A23V 2002/00 (2013.01); A61K 2236/15 (2013.01); A61K 2236/331 (2013.01); A61K 2236/37 (2013.01); A61K 2236/39 (2013.01); A61K 2236/51 (2013.01); A61K 2236/53 (2013.01); A61K 2236/55 (2013.01);
Abstract

The present disclosure relates to the field of drugs and health foods. Disclosed is a traditional Chinese medicine composition comprisingpolysaccharide,polysaccharide,oil andoil. Experiments show that the traditional Chinese medicine composition has a scientific formulation, synergistic functions, without toxic and side effects, and not only has nutritional value but also inhibits the growth of tumor. Comparing with individual components, the composition significantly increases the percentages of CD4and CD8cells in lymphocytes of the tumor stroma, increases body immune function, recovers normal immune surveillance function, decreases the expression rate of VEGF and TGF-β 1 positive cells in tumor tissue, assists in treating tumor, increases antitumor effects of chemotherapy drugs, improves immune status of body, has the function of restoring normal immune surveillance, preventing and assisting in treating tumor.


Find Patent Forward Citations

Loading…